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Abstract
Background: Mutant alleles of TMPRSS3  are associated with nonsyndromic recessive deafness (DFNB8/B10). TMPRSS3
encodes a predicted secreted serine protease, although the deduced amino acid sequence has no signal peptide. In this study,
we searched for mutant alleles of TMPRSS3 in families from Pakistan and Newfoundland with recessive deafness co-segregating
with DFNB8/B10 linked haplotypes and also more thoroughly characterized the genomic structure of TMPRSS3.
Methods: We enrolled families segregating recessive hearing loss from Pakistan and Newfoundland. Microsatellite markers
flanking the TMPRSS3 locus were used for linkage analysis. DNA samples from participating individuals were sequenced for
TMPRSS3. The structure of TMPRSS3 was characterized bioinformatically and experimentally by sequencing novel cDNA clones
of TMPRSS3.
Results: We identified mutations in TMPRSS3 in four Pakistani families with recessive, nonsyndromic congenital deafness. We
also identified two recessive mutations, one of which is novel, of TMPRSS3 segregating in a six-generation extended family from
Newfoundland. The spectrum of TMPRSS3 mutations is reviewed in the context of a genotype-phenotype correlation. Our study
also revealed a longer isoform of TMPRSS3 with a hitherto unidentified exon encoding a signal peptide, which is expressed in
several tissues.
Conclusion: Mutations of TMPRSS3 contribute to hearing loss in many communities worldwide and account for 1.8% (8 of 449)
of Pakistani families segregating congenital deafness as an autosomal recessive trait. The newly identified TMPRSS3 isoform e will
be helpful in the functional characterization of the full length protein.
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Background
Genetic analysis of inherited deafness is a powerful tool
for discovering the molecular mechanisms that control
the development, function and maintenance of the audi-
tory system. Linkage analysis of deafness segregating in
large families has resulted in the mapping of more than 55
non-overlapping loci and the discovery of over 30 genes
that are essential for hearing [1]. Given this extensive
genetic heterogeneity, extended families from endoga-
mous populations are ideally suited for identifying novel
deafness genes and for genotype-phenotype studies.
DFNB8/B10, an autosomal recessive deafness locus, was
independently mapped in two consanguineous families
from Palestine and Pakistan [2,3]. Haplotype and gene
sequence analyses of individuals in these two families led
to the identification of mutations in a gene encoding a ser-
ine protease, TMPRSS3 [4,5]. TMPRSS3 belongs to a sub-
family of type II transmembrane serine proteases, which
also includes TMPRSS1, TMPRSS2, TMPRSS4 and
TMPRSS5 [6]. The TMPRSS3  gene, spanning approxi-
mately 24 kb on chromosome 21, contains thirteen
reported exons [4]. In humans there are alternatively
spliced transcripts (TMPRSS3 a, b, c and d), encoding pre-
dicted polypeptides of 454, 327, 327 and 344 amino
acids, respectively [4]. Here, we report the identification
of a fifth isoform, TMPRSS3e, which encodes 538 amino
acid residues, including a signal peptide, and is expressed
in many human tissues.
We previously reported pathogenic TMPRSS3 mutations
in four out of a total of 159 Pakistani families segregating
profound congenital recessive deafness [5]. To determine
the contribution of TMPRSS3 mutations to recessive deaf-
ness in Pakistan, we screened an additional 290 Pakistani
families for linkage to the DFNB8/B10 locus. We also
screened TMPRSS3 for mutations in a large kindred from
Newfoundland, Canada segregating hearing loss linked to




Institutional review board approvals (OH93-N-016 and
OH95-DC-N-050) were obtained for this study from the
National Institutes of Health, USA, the Centre of Excel-
lence in Molecular Biology, Lahore, Pakistan and the
Newfoundland and Labrador Medical Genetics Program,
Health Sciences Centre, St. John's. Participating individu-
als gave written informed consent. Medical histories indi-
cated that all four Pakistani families segregate congenital,
profound, non-syndromic sensorineural hearing loss.
Pure tone air and bone conduction audiometry was per-
formed on affected and unaffected individuals of the fam-
ily from Newfoundland. Pneumatic otoscopy was used to
confirm or deny cases in which conductive hearing loss
was suspect. All testing was done in non-sound-attenu-
ated exam room. Prior to testing, a biologic calibration
was done in the room used for testing with a listener hav-
ing normal hearing thresholds (LS). Possible effects of
ambient noise on thresholds were then taken into account
and only those frequencies unaffected were included.
DNA was extracted from venous blood samples from the
participating individuals.
Linkage and sequence analyses
DNA samples were PCR amplified using fluorescently
labeled primers surrounding microsatellite repeats at
known DFNB loci and analyzed on an ABI 377 DNA
sequencer. Genotypes were determined using Genescan
and Genotyper software (PE Biosystems). To detect
TMPRSS3 mutations in families segregating DFNB8/B10,
the sequence of each exon of TMPRSS3 was evaluated in
two affected subjects from each family as described previ-
ously [5].
5' RACE and cloning of TMPRSS3e
Sequence analysis of the subcloned PCR product ampli-
fied from human retina GETLarge full length cDNA (Gen-
emed Biotechnologies) using primers
5'GGGTTGCTTCAAATGGCTTACTAGATCC3' and
5'CATTTTCCCCCATGGTGACTATTTCAG revealed an
additional 385 bp of transcribed sequence downstream of
TMPRSS3a exon 1. 5' RACE PCR using human retina Mar-
athon-Ready cDNA as template (Clontech) with primers
5'CAGACCAATGGCCAGTGCTAATATC3' and the AP1
primer was performed using the following thermal cycling
conditions: 94°C for 1 min, 25 cycles of 94°C for 30 s and
72°C for 5 min. Five microliters of amplified PCR product
was used for the second round of amplification with
nested primer 5'TTTTCAAATCATCAAGGCCAAAAAG3'
and the AP2 primer. Five microliters of each sample were
analyzed on a 1.2% agarose/ethidium bromide gel,
extracted using a QIAquick gel extraction kit (Qiagen) and
cloned into E. coli using pGEM®-T Easy vector (Promega).
DNA was purified from minipreps using QIAquick mini-
prep kit (Qiagen) and inserts were sequenced using T7
and SP6 primers. To amplify the full length TMPRSS3e
isoform, 5'ATGGTGAGTAAAATGGGTGTGAGGA3' and
5'CTTGGAAGTAGAAAGGGTGGGTTTG3' primers and
LA-Taq polymerase (Pan Vera) were used as recom-
mended by the manufacturers.
Multiple-tissue cDNA panel analysis
Expression of TMPRSS3e was evaluated using a Human
Tissue cDNA panel (Clontech). TMPRSS3e  cDNA was
amplified with primers
5'CCAGAAATGGTGAGTAAAATGG3' and
5'AGCAACAGCATCTGCATCTGGT3' using 20 pg of each
cDNA as template following the manufacturer's recom-BMC Medical Genetics 2004, 5:24 http://www.biomedcentral.com/1471-2350/5/24
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mended protocol (Clontech). PCR amplified products
were sub-cloned into pGEM-T Easy vector (Promega) and
sequenced.
Results
In four out of 290 newly investigated Pakistani families,
nonsyndromic congenital deafness was found to co-segre-
gate with DFNB8/B10 linked haplotypes (Figure 2). Muta-
tional analysis of DNA samples from the affected
individuals from these families (Table 1) revealed three
previously reported mutations (207delC, C407R, C194F).
In our families segregating 207delC there is a common
disease associated haplotype [5]. The second mutation,
C407R, was found previously in affected individuals of
two Pakistani families and in a heterozygous state in one
person of Indian descent. The same C407R ancestral hap-
lotype was also found in family PKDF040 [5]. The third
mutation, C194F, was reported in one Pakistani family
[5], which has the same haplotype as family PKDF064
(Figure 2).
After completing a genome wide screen we found linkage
of deafness to markers for DFNB8/B10 in one branch of a
large six-generation pedigree (Figure 1) from Labrador
Pedigree of Newfoundland family Figure 1
Pedigree of Newfoundland family. There are ten hearing impaired individuals in a six generation extended family struc-
ture. Drawn below the enrolled subjects is a haplotype for STR markers around the DFNB8/B10 locus on chromosome 21. 
The carrier status of each person for the mutant alleles of TMPRSS3 found in this family is shown. "C" represents 207delC, 
while "T" stands for IVS8+8insT. Individuals V:17 and V:20 are compound heterozygotes.BMC Medical Genetics 2004, 5:24 http://www.biomedcentral.com/1471-2350/5/24
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[7], a Canadian island whose small population lives in
villages isolated by geography and weather [8]. Medical
histories and pure tone air and bone conduction audiom-
etry revealed nonsyndromic, pre-lingual, severe to pro-
found, sensorineural hearing impairment in ten
participating affected individuals. Linkage analysis in this
family demonstrated homozygosity for DFNB8/B10
linked microsatellite markers among seven affected indi-
viduals from five different sibships (Figure 1). An appar-
ent founder DFNB8/B10 associated haplotype was
constructed using the available genetic information (Fig-
ure 1). Three hearing impaired individuals (IV:10, V:2 and
VI:1) carry only a single copy of the DFNB8/B10 haplo-
type, although their deafness is clinically indistinguisha-
ble from that of the five homozygotes.
Sequencing of the TMPRSS3 gene in affected individuals
revealed two mutant alleles. The first mutation occurs in
exon 4 of TMPRSS3 and is a deletion of a cytosine at posi-
tion 207 (207delC) of the mRNA (Figure 1, Table 1). The
second mutation inserts a "T" residue at the eighth posi-
tion after the splice donor site of exon 8 (IVS8+8insT).
Pedigrees of Pakistani families Figure 2
Pedigrees of Pakistani families. Four families with nonsyndromic recessive deafness from Pakistan.
Table 1: Mutant alleles of TMPRSS3 found in this study
Family Mutation Domain Amino acid substitution First reference
Family B IVS8+8insT SP Frameshift This study
Family B 207delC LDLRA Frameshift [9] 
PKDF003 207delC LDLRA Frameshift [9] 
PKDF040 1219T>C SP C407R [5] 
PKDF064 581G>T SRCR C194F [5] 
PKDF311 207delC LDLRA Frameshift [9] 
SP; Serine Protease, LDLRA; Low Density Lipoprotein Receptor A, SRCR; Scavenger-Receptor Cysteine-RichBMC Medical Genetics 2004, 5:24 http://www.biomedcentral.com/1471-2350/5/24
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Although the precise effect of this mutant allele is not
known, Genscan predicts this results in the skipping of
exon nine. Individual IV:16 is a carrier of IVS8+8insT and
her two affected children are compound heterozygotes
(Figure 1). Neither of these two mutations was found in
100 random normal control DNA samples (200 chromo-
somes) from Newfoundland.
We previously reported a Pakistani family (PKSR7) in
which deaf subjects were homozygous for the markers
spanning the DFNB8/B10 region with the simulated max-
imal lod score of 3.8 [5]. However, we did not find a
mutation in the known coding and non-coding exons of
TMPRSS3  [5]. One possible explanation is that family
PKSR7 has a mutation in a regulatory element of
TMPRSS3. Alternatively, there might be additional
uncharacterized exons of TMPRSS3. Considering the later
possibility, we searched for additional exons and alterna-
tively spliced transcripts of TMPRSS3. Previous studies
have documented four isoforms of TMPRSS3  [4]. To
probe for novel coding sequence of TMPRSS3  we
designed primers from the known exons to amplify
smaller overlapping cDNA product(s). The amplicon gen-
erated using a forward primer from the reported non-cod-
ing exon 1 and a reverse primer from the protein coding
region of exon 2 was larger than the expected size product
based on the sequence of TMPRSS3 isoform a [4]. After
subcloning and sequencing this transcript, an additional
385 bp of sequence was found at the 3' end of exon 1 [4].
We further confirmed the results by 5'RACE using gene
specific primers and human Marathon-Ready retina
cDNA as template. Using specific primers we amplified a
full-length transcript of this novel isoform, which we des-
ignated TMPRSS3e (Figure 3).
Although the ATG codon at position 705 (Accession #
AY633572) does not meet Kozak consensus criteria, there
are two reasons for believing that this is the translation
initiation site. First, there are stop codons in all three read-
ing frames upstream of this site. Secondly, the 252 bp
open reading frame between ATG 705 and ATG 957 (Fig-
ure 3A), the previously reported initiation codon,
includes a predicted signal peptide, which is expected in a
secreted serine protease. Considering the ATG at position
705 as a starting codon, analysis of the 1614 bp open
reading frame indicates that this larger TMPRSS3e tran-
script encodes a putative polypeptide of 538 amino acids,
including 84 previously unknown amino acids at the
amino terminus (Figure 3B and 3C). The SMART program
predicts a cleavable signal sequence between residues 1
through 36 (Figure 3A and 3B). Among all the known iso-
forms of TMPRSS3, only isoform e reported here has a pre-
dicted signal peptide, consistent with the hypothesis that
TMPRSS3 encodes a secreted serine protease. The remain-
ing 48 new amino acids do not contain other predicted
structural or functional motifs (Figure 3A and 3B). Down-
stream of the newly identified 84 amino acids, isoform e
shares a common protein sequence with isoform a, which
includes a transmembrane (TM), low density lipoprotein
receptor A (LDLRA), scavenger-receptor cysteine-rich
(SRCR) and serine protease domains (Figure 3A).
Through non-quantitative RT-PCR analysis with
TMPRSS3e specific primers and multiple human cDNAs,
we found expression of this isoform in retina, lung, liver,
pancreas, placenta and kidney (Figure 3C). Mutational
screening of exon 1 and exon 2 as well as other exons of
TMPRSS3e, using DNA samples from two affected individ-
uals of family PKSR7 did not reveal a pathogenic change.
This may be an indication of as yet uncharacterized addi-
tional exons of TMPRSS3, or the hearing loss phenotype
in this family is due to a mutation in a regulatory element
of TMPRSS3. Alternatively, it remains possible that family
PKSR7 has a mutation in a gene closely linked to
TMPRSS3.
Discussion
TMPRSS3  is the only protease reported thus far to be
involved in nonsyndromic deafness [4]. In this study, we
document the mutant alleles of TMPRSS3 segregating in a
large family from Newfoundland and in additional Paki-
stani families with nonsyndromic, recessive deafness. The
Newfoundland family has at least two different mutated
genes associated with hearing impairment. The majority
of the affected individuals in this family are homozygous
for 207delC (Figure 1), while two of the hearing impaired
subjects are compound heterozygotes for 207delC and a
newly described mutation of intron 8 (IVS8+8insT). The
207delC mutation appears to be wide-spread; it has been
found in affected individuals of Spanish (one homozy-
gote), Greek (one heterozygote), Newfoundland
(homozygous individuals) and Pakistani (homozygous
individuals, PKDF003 and PKDF311) origins, and is the
most common of the mutant alleles of TMPRSS3.
Although there is a predicted effect of IVS8+8insT muta-
tion on splicing of exon 9, further studies are required to
determine the precise role of IVS8+8insT on TMPRSS3
transcripts. The family from Pakistan that originally
defined the DFNB8 locus was reported to have childhood
onset hearing impairment [3], while all remaining fami-
lies segregating TMPRSS3  mutations have pre-lingual
deafness [4,5,9,10]. Mutational screening revealed a splice
site mutation (IVS4-6G>A) in the original DFNB8 family,
which may allow some normal splicing of TMPRSS3 tran-
scripts [4]. The second mutant allele (IVS8+8insT) in the
Newfoundland family may also be a leaky mutation,
although the two individuals who are compound hetero-
zygotes were described as having prelingual hearing
impairment.BMC Medical Genetics 2004, 5:24 http://www.biomedcentral.com/1471-2350/5/24
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Mutational spectrum, structure and expression of TMPRSS3 isoforms Figure 3
Mutational spectrum, structure and expression of TMPRSS3 isoforms. (A) Coding and non-coding exons of all the 
known isoforms of TMPRSS3 are shown with black and gray rectangles, respectively. The newly identified isoform e has trans-
lation initiation codon (arrow) in exon 1, while the termination codon in exon 13 is marked with an asterisk. Shown also are 
predicted protein motifs encoded by the 3192 bp long mRNA of isoform e. All the known mutant alleles of TMPRSS3 causing 
hearing loss are shown above the protein motifs. Modified and updated from Ben-Yosef et al. 2001 [5] (B) Nucleotide 
sequence of the cDNA encoding the amino terminus of TMPRSS3e and its deduced amino acid sequence. The underlined nucle-
otide sequence represents the region predicted by SMART to encode a signal peptide. The last ATG shown is the reported 
translation initiation site for isoform a [4]. (C) RT-PCR specific to the TMPRSS3e transcript was performed on cDNA from 
seven human tissues, which include retina, lung, liver, heart, pancreas, placenta and kidney as indicated. All tissues, except 
heart, demonstrated expression of TMPRSS3e. G3PDH was used as a positive control.BMC Medical Genetics 2004, 5:24 http://www.biomedcentral.com/1471-2350/5/24
Page 7 of 8
(page number not for citation purposes)
The hearing impaired individuals IV:10, V:2 and VI:1 of
our Newfoundland family are carriers of 207delC and we
did not find any other TMPRSS3 mutation in these indi-
viduals. Individuals IV:10 (affected) and IV:12 (normal
hearing sibling) show an identical chromosome 21 haplo-
type. Similarly the individuals VI:1 (affected) and VI:2
(normal hearing sibling) share identical haplotypes for
the TMPRSS3 locus. Hence, it is unlikely that the deafness
of individuals IV:10 and VI:1 is due to cryptic TMPRSS3
mutations (Figure 1). As connexin 26 mutations are the
most common cause of nonsyndromic recessive deafness
[11], we sequenced the coding exon of GJB2 in affected
individuals of Newfoundland family and found no
mutation.
We have analyzed a total of 449 Pakistani families [[5]
and this study] segregating severe to profound congenital
recessive deafness and found a total of eight families in
which the deafness phenotype is due to mutations of
TMPRSS3. Therefore, the relative contribution of
TMPRSS3 mutations in the deaf Pakistani population is
approximately 1.8%, a significant amount considering the
extensive genetic heterogeneity of deafness in this popula-
tion. Of ten TMPRSS3 mutations that have been reported
world wide, five (IVS4-6G>A, 207delC, R109W, C194F
and C407R) are segregating in the Pakistani population
[4,5,9,10].
Among the ten known mutant alleles of TMPRSS3, six are
present in exons common to all isoforms, including iso-
form "e" reported herein. Of the isoforms of this serine
protease, TMPRSS3e has the longest open reading frame
and is the only isoform of this gene with a predicted signal
sequence at the amino terminus. The identification of 84
additional amino acids, including a predicted signal
sequence, may aid functional assays to determine the role
of  TMPRSS3  in cochlear development and function.
TMPRSS3 isoform a was identified with a forward primer
(TMa-F; see supplement table B [4]) in exon 2 and not in
exon 1 as illustrated in figure 1 of Scott et al. 2001 [4].
Therefore, it is possible that TMPRSS3a is an incomplete
version of isoform e and isoform a may not exist in vivo.
TMPRSS3 message is expressed in supporting cells of the
organ of Corti, in the stria vascularis and in the spiral gan-
glion cells of the cochlea [12]. Although the specific role
of TMPRSS3 in the development and maintenance of the
audiosensory apparatus is still unknown, the reported
mutant alleles of TMPRSS3 abolish catalytic activity of the
serine protease, implying a proteolytic function during
the inner ear development [12,13]. Although the in vivo
substrate(s) of TMPRSS3 have not been reported in the
auditory system, TMPRSS3 is thought to regulate the activ-
ity of the epithelial amiloride sensitive sodium channel
(ENaC) in vitro, which was suggested to control critical sig-
naling pathway(s) in the inner ear and may have a role in
the maintenance of the low sodium concentration of
endolymph [12]. However, the absence of an abnormal
auditory phenotype in individuals with Pseudohy-
poaldosteronism type I (PHA 1), which are homozygous
for null alleles of ENaC subunits [14], suggests that the
DFNB8/B10 deafness phenotype is due to aberrant
proteolytic processing by TMPRSS3 of some other sub-
strate in the inner ear.
Conclusions
TMPRSS3 mutations account for hearing loss in 1.8% (8
of 449) of Pakistani families segregating deafness as an
autosomal recessive trait. We also identified two recessive
mutations of TMPRSS3  segregating in a six-generation
extended family from Newfoundland. Our study also
revealed a longer isoform of TMPRSS3  with an exon
encoding a signal peptide, which should help in the func-
tional dissection of this secreted serine protease.
Abbreviations
TMPRSS3; Transmembrane Protease, Serine 3 [OMIM
entry 605511].
DFNB8; Deafness, childhood-onset neurosensory auto-
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ness, congenital neurosensory, autosomal recessive 10
[OMIM entry 605316]
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